Medication info
Gatis Tablet

Gatis Tablet

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201800979 · Approved 2018.02.27

Summary

Main use
Treatment of gastrointestinal disorders (including ulcers), treatment of Zollinger-Ellison syndrome, and prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, administer 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily, or 4 tablets as a single dose once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets as a single dose once daily at bedtime for maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks, or 4 tablets as a single dose once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets as a single dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets as a single dose on the night before surgery.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (including ulcers), treatment of Zollinger-Ellison syndrome, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs
View approved original text

This medication is used in the treatment of ulcers occurring in the stomach and duodenum, as well as gastritis and gastroesophageal reflux disease. It is also effective for diseases with excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It helps prevent postoperative ulcers and treats gastric and duodenal ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Additionally, it is administered to prevent Mendelson's syndrome before anesthesia. It is used to improve various gastrointestinal-related disorders.

How to take

Adult dose

Usually, administer 2 tablets per dose orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily, or 4 tablets as a single dose once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets as a single dose once daily at bedtime for maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks, or 4 tablets as a single dose once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets as a single dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets as a single dose on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or with kidney function issues. Additionally, patients who have had allergic reactions to this medication or its ingredients should not be administered this drug. It is not recommended for patients with a history of acute porphyria, those who have undergone upper gastrointestinal tract surgery, pregnant women or women who may become pregnant, premature and newborn infants, or patients who are on a diet that restricts potassium intake. Caution should be exercised when administering this medication to patients with liver function abnormalities, a history of drug allergies, the elderly, or patients with kidney issues. Special attention is required when taking nonsteroidal anti-inflammatory drugs together, and elderly patients with a history of peptic ulcer disease require regular observation. This medication may mask the symptoms of gastric cancer, so patients with gastric ulcers or newly developed dyspeptic symptoms in middle-aged or older individuals should confirm the absence of malignancy before treatment. Eradication therapy is necessary for patients with Helicobacter pylori-associated gastric and duodenal ulcers. It is also important to exercise caution when administering this medication to severely ill ICU patients, patients with hypophosphatemia, or those with swallowing difficulties. This medication can rarely cause severe allergic reactions, such as anaphylactic shock, so symptoms should be closely monitored during administration. If skin rash, urticaria, angioedema, or bronchospasm occur, administration should be stopped immediately. Reported abnormalities in blood tests include leukopenia, thrombocytopenia, and liver function abnormalities, so if unusual symptoms occur, discontinue use and take appropriate measures. Cardiac arrhythmias, gastrointestinal symptoms, dizziness, drowsiness, and mental confusion may also occur, requiring caution. Long-term use should be avoided, and it is advisable to switch to another medication if there is no therapeutic effect. Regular blood, liver, and kidney function tests during the course of treatment are important. There may be an increased risk of pneumonia in the elderly or those with chronic diseases, so caution is warranted. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so disclose any other medications being taken. Special care is needed when combined with certain anticoagulants or antibiotics and should be closely monitored through blood tests. It is safest for pregnant or breastfeeding women to avoid using this medication. Safety in children has not been established, so administration is not recommended. In case of overdose, emergency treatments such as inducing vomiting or gastric lavage may be needed, and blood dialysis can be performed if necessary. This medication may promote bacterial growth in the stomach by reducing gastric acid secretion, so ocular examinations may be necessary with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • leukopenia
Show 58 more
  • thrombocytopenia
  • serum creatinine elevation
  • serum aminotransferase elevation
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • AST elevation
  • ALT elevation
  • r-GTP elevation
  • ALP elevation
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • disease sense
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorder
  • consciousness disorder
  • hypertrophic muscular cramps
  • gynecomastia
  • hyperlactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • skin itching
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering and kept at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.